Why is "Atypical antipsychotics" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-04-07 02:30:42
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
The atypical antipsychotics (AAP), also known as second generation antipsychotics (SGAs) and serotonin–dopamine antagonists (SDAs), are a group of antipsychotic drugs largely introduced after the 1970s and used to treat psychiatric conditions. Some atypical antipsychotics have received regulatory approval for schizophrenia, bipolar disorder, irritability in autism, and as an adjunct in major depressive disorder.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Bristol-Myers Squibb Says Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition From Oral Atypical Antipsychotics To Cobenfy - TradingView — Track All Markets
-
Confessions of an Ad Writer: How I Helped Turn Atypical Antipsychotics into a Billion-Dollar Industry - Mad In America
-
Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition from Oral Atypical Antipsychotics to Cobenfy™ (xanomeline and trospium chloride) - BioSpace
-
Characteristics of Eye Disorders Induced by Atypical Antipsychotics - Physician's Weekly
-
What Medications Are Most Effective in Children With Bipolar Disorder? - Child Mind Institute
-
New Insights Into Xanomeline/Trospium - Psychiatrist.com
-
FDA turns down Lundbeck, Otsuka's Rexulti in PTSD on lack of efficacy data - Fierce Pharma
-
How Does the Efficacy, Safety of Cobenfy Compare to Atypical Antipsychotics? - Psychiatry Advisor
-
Bipolar Depression: Choosing the Right Antipsychotic - Medscape Reference
-
Treatment Comparison: Somnolence/Sedation With Dopamine Partial Agonists vs D2 Receptor Antagonists - Psychiatric Times
-
Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape | American Journal of Psychiatry - Psychiatry Online
-
Evaluation of atypical antipsychotics associated rhabdomyolysis using the FDA adverse event reporting system database - Nature
-
Mechanistic Complications With Atypical Antipsychotics for Parkinson Disease Psychosis: Dilesh Doshi, PharmD - NeurologyLive
-
Atypical Antipsychotics Show Promise for Adjunctive Role in Treating Chronic Pain Syndromes - Cleveland Clinic
-
Cobenfy as Add-On Treatment for Schizophrenia Fails to Meet Primary Endpoint in Phase 3 ARISE Trial - Psychiatric Times
-
Pimavanserin Lowers Mortality Better in Parkinson Disease Than Other Atypical Antipsychotics - NeurologyLive
-
Mortality Among Parkinson’s Disease Patients Treated With Pimavanserin or Atypical Antipsychotics: An Observational Study in Medicare Beneficiaries - Psychiatry Online
-
A potential mechanism underlying atypical antipsychotics-induced lipid disturbances - Nature
-
Accumulation of Reproductive Safety Data for Second-Generation Atypical Antipsychotics: A Call to Accelerate the Process - Psychiatrist.com
-
Do We Need a New Nomenclature for Atypical Antipsychotics? A Survey of Health Care Professionals and Patients - Psychiatrist.com
-
Pimavanserin and Clozapine Outperform Other Atypical Antipsychotics in Treating Parkinson Disease Psychosis - NeurologyLive
-
Bristol Myers' schizophrenia drug Cobenfy stumbles as adjunctive treatment, denting blockbuster plan - Fierce Pharma
-
receptors in the ventral tegmental area GABA neurons to relieve psychotic behaviors - Nature
-
Risk of Akathisia Associated With Atypical Antipsychotics - Psychiatry Online
-
Atypical Antipsychotics May Dysregulate Immune Response, Increase Risk for COVID-19 - Psychiatry Advisor
-
Bristol Myers’ prized schizophrenia drug stumbles in testing - BioPharma Dive
-
Off-label use of atypical antipsychotics- Where are we? - Cambridge University Press & Assessment
-
Atypical Antipsychotics as Adjuncts in Chronic Pain Management: How Effective Are They? - Clinical Pain Advisor
-
Higher-Dose Atypical Antipsychotics Risky in Young Adults - Medscape
-
Bristol Myers Squibb’s Cobenfy Falls Short in Phase III Trial as Add On Therapy for Schizophrenia - Pharmaceutical Executive
-
A Program for Managing Weight Gain Associated With Atypical Antipsychotics - Psychiatry Online
-
Atypical antipsychotics linked with acute kidney injury in the elderly - 2 Minute Medicine
-
Treatment Adherence Associated With Conventional and Atypical Antipsychotics in a Large State Medicaid Program - Psychiatry Online
-
How Atypical Antipsychotics Work in Parkinson’s Psychosis - HealthCentral
-
Atypical antipsychotics: overrated and overprescribed - The Pharmaceutical Journal
-
Reproductive Safety of Second-Generation Antipsychotics: Updated Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics - Psychiatrist.com
-
The long-acting injectable atypical antipsychotics—merits and demerits! | CNS Spectrums | Cambridge Core - Cambridge University Press & Assessment
-
List of Tier I and Tier II drugs. Tier II drugs can be both individually named drugs and classes of drugs (e.g., atypical antipsychotics). - National Institute of Justice (.gov)
-
Antipsychotics vs. Mood Stabilizers for Acute Mania in Youth - Psychiatry Online
-
The rise and fall of the atypical antipsychotics - Cambridge University Press & Assessment
-
Cardiovascular Risk of Concomitant Use of Atypical Antipsychotics and Stimulants Among Commercially Insured Youth in the United States - Frontiers
-
Risperidone Treatment Not Linked to Osteoporosis Fracture Risk - Rheumatology Advisor
-
SUMMARY WITH ACTION PLAN - National Institutes of Health (.gov)
-
Increased Sensitivity to Atypical Antipsychotics in a Patient With Dandy-Walker Variant With Schizophrenia - Psychiatry Online
-
Atypical antipsychotics for Attention-Deficit/Hyperactivity disorder- science, art, or fad? - Cambridge University Press & Assessment
-
Adjunctive Atypical Antipsychotics in Major Depressive Disorder: What’s the Impact? - Psychiatric Times
-
Risk of Poor Neonatal Adaptation Syndrome Among Infants Exposed to Second-Generation Atypical Antipsychotics Compared to Antidepressants: Results From the National Pregnancy Registry for Psychiatric Medications - Psychiatrist.com
-
Atypical antipsychotics in bipolar disorder: the treatment of mania - Cambridge University Press & Assessment
-
Different Effects of Typical and Atypical Antipsychotics on Grey Matter in First Episode Psychosis: the ÆSOP Study - Nature
-
The modulation of adult neuroplasticity is involved in the mood-improving actions of atypical antipsychotics in an animal model of depression - Nature
-
Antipsychotics May Help Patients Experiencing Pain - Psychiatry Online
-
Acute Effects of Atypical Antipsychotics on Whole-Body Insulin Resistance in Rats: Implications for Adverse Metabolic Effects - Nature
-
A schizophrenia win for BMS’ Cobenfy, but challenges lie ahead - Clinical Trials Arena
-
Atypical antipsychotics not safer than haloperidol for older adults with postoperative delirium: Study - Medical Xpress
-
Antipsychotic medications: a timeline of innovations and remaining challenges - Our World in Data
-
Second-generation antipsychotics and metabolic syndrome: a role for mitochondria - Frontiers
-
Atypical antipsychotics in schizophrenia - Hospital Pharmacy Europe
-
Antipsychotics Appear Effective For Borderline Personality Disorder - Psychiatry Online
-
Contrasting Typical and Atypical Antipsychotic Drugs - Psychiatry Online
-
Adjunctive Ziprasidone in Major Depression and the Current Status of Adjunctive Atypical Antipsychotics - Psychiatry Online
-
Atypical antipsychotic‐associated falls in older adults - Lam - 2018 - The Brown University Psychopharmacology Update - Wiley Online Library
-
Managing Safety Concerns of Atypical Antipsychotics in Elderly Patients with Dementia - Medical Professionals Reference
-
Structural effects of atypical antipsychotics: Implications for the meaning of cortical volume deficit in schizophrenia - SciELO España
-
Risk of pregnacy when changing to atypical antipsychotics - Cambridge University Press & Assessment
-
Off-label use of atypical antipsychotics: Lack of evidence for their use in primary insomnia - Managed Healthcare Executive
-
Reproductive Safety of Second-Generation Antipsychotics: Current Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics - Psychiatry Online
-
Novel Drug Associations Found with Floppy Iris Syndrome - Review of Optometry
-
Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D - Nature
-
The use of atypical antipsychotics in the treatment of catatonia - Cambridge University Press & Assessment
-
Adjunctive Antipsychotic Therapies in the Treatment of Major Depressive Disorder - Psychiatry Advisor
-
Trazodone No Better Than Other Atypical Antipsychotics For Treating Older Dementia Patients: Study - AboutLawsuits.com
-
Atypical Antipsychotics and a Src Kinase Inhibitor (PP1) Prevent Cortical Injury Produced by the Psychomimetic, Noncompetitive NMDA Receptor Antagonist MK-801 - Nature
-
Intra-Cellular's Caplyta could cruise toward blockbusterland with bipolar depression win: analyst - Fierce Pharma
-
A molecular mechanism mediating clozapine-enhanced sensorimotor gating - Nature
-
Older Parkinson’s Patients Often Wrongly Given Antipsychotics, Study Says - Parkinson's News Today
-
Schizophrenia therapy: beyond atypical antipsychotics - Nature
-
Antipsychotics for anxiety: Types, uses, and more - Medical News Today
-
Effects of Typical and Atypical Antipsychotics and Receptor Selective Compounds on Acetylcholine Efflux in the Hippocampus of the Rat - Nature
-
APA 2021 Roundup: New Antipsychotic Class, Anxious America - MedPage Today
-
Some Antipsychotics Still Overused After In-Hospital Delirium - MedPage Today
-
Cariprazine May Decrease Substance Abuse in Patients With Bipolar I Disorder - Psychiatric Times
-
Caspase-3 Activation in Rat Frontal Cortex Following Treatment with Typical and Atypical Antipsychotics - Nature
-
Medicaid Access Restrictions on Psychiatric Drugs: Penny-Wise or Pound-Foolish? - February 2, 2015 - USC Schaeffer
-
The Effectiveness of High-Dosage Amisulpride Combined With Moderate-Dosage Sodium Valproate Treatment for an Overweight Patient With Psychotic Bipolar Disorder - Psychiatry Online
-
Dual Therapy for Depression; Ties Between Illicit Drug Use and Youth Suicidality - MedPage Today
-
Switching atypical antipsychotics: a review - Cambridge University Press & Assessment
-
Prevention of antipsychotic-induced hyperglycaemia by vitamin D: a data mining prediction followed by experimental exploration of the molecular mechanism | Scientific Reports - Nature
-
Intra-Cellular's unstoppable Caplyta nails another trial, this time for relapse prevention in schizophrenia - Fierce Pharma
-
Atypical antipsychotic causes weight gain by targeting serotonin receptor 2C - The Pharmaceutical Journal
-
Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease - NEJM
-
Adding Vitamin D May Reduce Side Effect of Certain Antipsychotic Drugs - Medical Professionals Reference
-
PTSD and Psychiatric Medication Linked to Dementia in Older Veterans - Mad In America
-
Use of atypical antipsychotic drugs in old age psychiatry - Cambridge University Press & Assessment
-
New Monthly Paliperidone Palmitate Injectable OK'd for Schizophrenia - MedPage Today
-
Aka-what? Fanapt maker Vanda puts antipsychotic side effect front and center in TV awareness ads - Fierce Pharma
-
What Are Typical Antipsychotics? - Verywell Mind
-
Audit Finds Widespread Use Of Antipsychotic Drugs In Nursing Homes : Shots - Health News - NPR
-
Psychotropic Medications: Types, Their Use, and Side Effects - Healthline
-
Zyprexa: Also a Pain Med? - MedPage Today
-
Study: Schizophrenia drugs in kids cause weight gain - CNN
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.